Education
About Us
Working with TipRanks
Follow Us
Zymeworks Inc (ZYME)
NASDAQ:ZYME
Total Valuation
Zymeworks has a market cap or net worth of $916.10M. The enterprise value is $738.97M.
Market Cap$916.10M
Enterprise Value$738.97M
Share Statistics
Zymeworks has 69,683,495 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding69,683,495
Owned by Insiders25.61%
Owned by Institutions0.71%
Financial Efficiency
Zymeworks’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -33.39%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-33.39%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee255.20K
Profits Per Employee-410.35K
Employee Count299
Asset Turnover0.16
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zymeworks is -9.05. Zymeworks’s PEG ratio is 0.95.
PE Ratio-9.05
PS Ratio0.00
PB Ratio2.53
Price to Fair Value<0.01
Price to FCF-6.98
Price to Operating Cash Flow-7.81
PEG Ratio0.95
Income Statement
In the last 12 months, Zymeworks had revenue of 76.30M and earned -122.69M in profits. Earnings per share was -1.62.
Revenue76.30M
Gross Profit65.11M
Operating Income-119.82M
Pretax Income-116.61M
Net Income-122.69M
EBITDA-105.42M
Earnings Per Share (EPS)-1.62
Cash Flow
In the last 12 months, operating cash flow was -109.78M and capital expenditures -314.00K, giving a free cash flow of -112.65M billion.
Operating Cash Flow-109.78M
Free Cash Flow-112.65M
Free Cash Flow per Share-1.62
Dividends & Yields
Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change45.86%
50-Day Moving Average12.23
200-Day Moving Average13.14
Relative Strength Index (RSI)59.49
Average Volume (3m)460.78K
Important Dates
Zymeworks upcoming earnings date is Jul 31, 2025, Before Open (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Zymeworks as a current ratio of 3.40, with Debt / Equity ratio of 5.46%
Current Ratio3.40
Quick Ratio3.40
Debt to Market Cap14.17
Net Debt to EBITDA451.77
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zymeworks has paid 6.08M in taxes.
Income Tax6.08M
Effective Tax Rate-0.05
Enterprise Valuation
Zymeworks EV to EBITDA ratio is 441.24, with an EV/FCF ratio of 411.23.
EV to Sales-609.60
EV to EBITDA441.24
EV to Free Cash Flow411.23
EV to Operating Cash Flow422.69
Balance Sheet
Zymeworks has $225.78M in cash and marketable securities with $18.51M in debt, giving a net cash position of -$207.27M billion.
Cash & Marketable Securities$225.78M
Total Debt$18.51M
Net Cash-$207.27M
Net Cash Per Share-$2.97
Tangible Book Value Per Share$4.25
Margins
Gross margin is 45.45%, with operating margin of -157.03%, and net profit margin of -160.80%.
Gross Margin45.45%
Operating Margin-157.03%
Pretax Margin-152.82%
Net Profit Margin-160.80%
EBITDA Margin-138.16%
EBIT Margin-157.03%
Analyst Forecast
The average price target for Zymeworks is $23.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$23.80
Price Target Upside82.52% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast85.05%
EPS Growth Forecast15.96%